Table 1 Clinico-pathological details of 101 patients receiving radical cystectomy evaluable on TMA for TÂ cell and TME-panel with multiplex immunohistochemistry.
|  |  | n = 101 |
|---|---|---|
Median age (IQR) | 68 (59–75) | |
Gender | ||
 Male | 78 (77%) | |
 Female | 23 (23%) | |
Max. tumor-stage | ||
 pT2 | 24 (24%) | |
 pT3 | 57 (56%) | |
 pT4 | 20 (20%) | |
Lymph node status | ||
 pN0 | 49 (49%) | |
 pN+/pNx | 52 (51%) | |
Histological subtype | ||
 NOS | 73 (72%) | |
 Squamous | 11 (11%) | |
 Micropapillary | 6 (6%) | |
 Neuroendocine | 3 (3%) | |
 Sarcomatoid | 2 (2%) | |
 Plasmacytoid | 2 (2%) | |
 Other (2 Lymphoepithelial, 1 Glandular, 1 Giant cell) | 4 (4%) | |
Min. 2 cycles adjuvant chemotherapy | ||
 No | 67 (66%) | |
 Yes | 34 (34%) | |